vimarsana.com

Page 53 - டைவாந் வாழ்க்கைத்தொழில்கள் அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

郭台銘終於感謝「北京皇恩浩蕩」?開講無疆界 - 讀者投書 新頭殼 Newtalk

生意人無奸不成商,原來郭台銘所含藏的匕首就是,北京未有任何「指導或干涉」,感謝習皇帝能以蒼生為念「北京皇恩浩蕩」?然實際情況如此嗎? 首先,此次疫苗採購過程未有任何「指導或干涉」?事實上,中國國台辦打從一開始即強調「上海復星的代理權」,絲毫沒有鬆動。這次台積電、永齡基金會與上海復星醫藥集團簽署採購BNT疫苗,是由國台辦官方證實已簽約的,何來單純的民間商業採購契約?如果真是所謂的「獨家權益」與「商業規則」,國台辦實在不必多嘴。這樣的宣示徒增台灣民眾反感,是共產黨笨嗎?非也,只要能夠逮到分化台灣社會的目的中共不會手軟的! 其次,上海復星昨晚公告,分別與台積電、永齡基金會簽訂《銷售協議》,將銷售一千萬劑mRNA新冠疫苗,該等疫苗將被買方捐贈予「台灣地區」疾病管制機構用於當地

Mainland company signs COVID-19 vaccine sales deals with Taiwan enterprises

Mainland company signs COVID-19 vaccine sales deals with Taiwan enterprises Xinhua | Updated: 2021-07-12 09:12 Share CLOSE A Taiwan compatriot receives a dose of COVID-19 vaccine at Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine in East China s Shanghai, April 19, 2021. [Photo/Xinhua] SHANGHAI - A Chinese mainland company has signed agreements with Taiwan enterprises and a foundation on COVID-19 vaccine sales, according to an announcement the company released Sunday. A subsidiary of Shanghai-based Fosun Pharmaceutical Group Co. Ltd. will sell 10 million doses of mRNA COVID-19 vaccines to Taiwan Semiconductor Manufacturing Co., Ltd., Hon Hai Precision Industry Co., Ltd., and Yonglin Charity Foundation, according to the announcement.

Politics, health collided in Taiwan s tortured BioNTech vaccine talks

Politics, health collided in Taiwan s tortured BioNTech vaccine talks
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

US-Taiwan s cross-strait status quo with mainland China unlikely to change - New Delhi Times

US-Taiwan s cross-strait status quo with mainland China unlikely to change - New Delhi Times
newdelhitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newdelhitimes.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.